Mangoceuticals (MGRX) Net Cash Flow (2023 - 2026)

Mangoceuticals has disclosed Net Cash Flow across 4 years of filings, most recently posting -$1.3 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$1.3 million, down 12932.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $99038.0 (up 6073.34% YoY), and the FY2025 annual result was $1.4 million, up 311.87% from the prior year.
• Net Cash Flow came in at -$1.3 million for Q1 2026 at Mangoceuticals, down from $1.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $3.2 million in Q1 2023 to a low of -$1.7 million in Q3 2023.
• The 4-year median for Net Cash Flow is -$7077.0 (2024), against an average of -$43854.2.
• Across the five-year window, Net Cash Flow soared 14311.36% in 2025 and plunged 12932.4% in 2026, its largest moves.
• Mangoceuticals' Net Cash Flow stood at -$497741.0 in 2023, then jumped by 98.58% to -$7077.0 in 2024, then jumped by 14311.36% to $1.0 million in 2025, then slumped by 230.39% to -$1.3 million in 2026.
• The last three Net Cash Flow figures came in at -$1.3 million (Q1 2026), $1.0 million (Q4 2025), and $380307.0 (Q3 2025), per Business Quant data.